Merck KGaA launched "Curiosity," a new branding campaign that features influencer scientist Carl Naughton guiding users through the German drugmaker's interactive website. The campaign aims to "spark a discussion within our social communities about curiosity as the starting point of scientific progress and innovation," says Merck spokesman Gangolf Schrimpf.
Seventy-nine percent of US consumers only consider purchasing from brands that demonstrate they understand and care about consumers, Wunderman reports. The study also highlighted the importance of a good mobile experience, with 90% of US respondents saying mobile enables them to make better buying decisions.
A Transparency Market Research report predicts the US market for implantable medical devices will reach $73.9 billion by 2018 with an 8% compound annual growth rate. Market growth is being driven by an expanding aging population, increasing health care expenditures and a growing incidence of chronic degenerative diseases.
AOL has launched BrandBuilder to help advertisers circumvent ad blocking by creating native and custom ads that provide a better, more valuable experience to consumers. Player Up shows less intrusive spots before users watch a video, and DataPerks gives mobile users extra Verizon data in return for clicking on an ad and entering information such as an email address.
The Interactive Advertising Bureau and the American Association of Advertising Agencies are calling on the industry to adopt an open-source project to introduce a standard mobile app viewability measurement. The IAB will lead the initiative to develop a third-party tracking code, and observers are hopeful that Google and Facebook will be open to the project.
Boehringer Ingelheim and Eli Lilly and Co.'s supplemental new drug applications for three type 2 diabetes drugs -- Glyxambi, Synjardy and Synjardy XR -- have been approved by the FDA. Their labels will now include data showing that the drugs can reduce the risk of cardiovascular deaths compared with placebo when added to standard of care medicines for adults with type 2 diabetes and cardiovascular disease.
House Speaker Paul Ryan, R-Wis., said Republican lawmakers intend to write legislation this year to replace the Affordable Care Act, responding to concerns that the law would be repealed without a clear alternative. Congressional Republicans have not been clear on whether any replacement would cover everyone currently covered through ACA exchanges, but Kellyanne Conway, an adviser to President-elect Donald Trump, reiterated his campaign promises, stating, "We don't want anyone who currently has insurance to not have insurance."
Creatives who work hard and have fun at the same time will be more likely to produce outstanding work, says Paddy Fraser, creative director at CP+B LA. Advertising is entertainment, he says, and if creatives don't enjoy what they're doing, it will reflect in their work.
The FDA plans to conduct research into whether health care professionals (HCPs) and consumers can identify deceptive claims in prescription drug promotion and could expand the agency's Bad Ad program to consumers if the study finds that consumer reporters would add value to that program, the FDA announced Jan 4. How well consumers and HCPs can identify deceptive promotion has "important public health implications," according to the FDA's notice in the Federal Register. Read more.
Today, consumers expect businesses to adapt to their needs and our findings are consistent across all generations, geographies and genders.
Jamie Gutfreund, global CMO of Wunderman, on appealing to consumers in 2017. Read more from Adweek.